Skip to content
My WebMD Sign In, Sign Up
latest drug news
  1. FDA Approves Skin Patch for Migraines

    The FDA has approved the Zecuity (sumatriptan) skin patch system for treatment of adults who have migraine with or without aura. The single-use, battery-powered patch offers relief of migraine-related nausea as well as migraine headache pain.

  2. FDA Requires Lower Dosage for Popular Sleep Drugs

    The FDA is requiring manufacturers of certain popular sleep medications such as Ambien and Zolpimist to cut current recommended doses in half for women.

  3. FDA Approves New Blood Thinner Eliquis

    The FDA has approved the blood thinner Eliquis to prevent stroke in people with atrial fibrillation.

  4. Recall of More Hydrocodone-Acetaminophen Tablets

    More lots of the combination painkiller hydrocodone-acetaminophen are being recalled by Mylan Institutional. The new alert follows a nationwide recall of 101 lots of the drugs issued by Qualitest Pharmaceuticals that occurred earlier this month.

  5. FDA Approves Tamiflu for Infants

    Children as young as 2 weeks old may now be treated for the flu with Tamiflu.

  6. FDA Warns of Fatal Rash From Hep C Drug Incivek

    The FDA warned people taking the hepatitis C drug Incivek (telaprevir) that it has received reports of a serious skin rash from the medication, which has led to several deaths.

  7. Generic Lipitor Recall

    Ranbaxy Pharmaceuticals Inc., a major maker of generic Lipitor, has issued a massive recall of the cholesterol-cutting tablets, which may be contaminated with tiny glass shards.

  8. New Arthritis Drug Xeljanz Gets FDA Approval

    The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis.

  9. 2nd Pharmacy Recalls Thousands of Drugs

    Ameridose, a Massachusetts compounding pharmacy closely linked to the NECC pharmacy at the heart of the fungal meningitis outbreak, today recalled thousands of drugs sold to hospitals across the U.S.

  10. FDA Approves Synribo for Drug-Resistant Leukemia

    The FDA has approved Teva's Synribo (omacetaxine mepesuccinate) for treating adults with chronic myelogenous leukemia (CML).

Find a Drug:

by name or medical condition or shape/color (Pill Identifier)

(for example: aspirin)

(for example: diabetes)

Report Problems to the Food and Drug Administration
 
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Ask the pharmacist

Questions about medications? Get expert answers by video or live chat about allergies, pregnancy, sleep, and more.
See the Ask the Pharmacist event schedule.

Ask a Question

Popular Slideshows & Tools on WebMD

feet
Solutions for 19 types.
highlighted areas of the brain
How well do you know yours?
oatmeal and eggs
The best and worst for you.
dog begging at table
Foods your dog should never eat.
MS Overview
Recognizing symptoms.
mature woman with serious expression
What do you know?
chlamydia
Pictures and facts.
Healthy Snack
13 delicious options.
Take your medication
Separate fact from fiction.
lone star tick
How to identify that bite.
young woman in sun
What to watch for.
woman clutching at stomach
Do you know what's causing yours?

Women's Health Newsletter

Find out what women really need.

WebMD the app

Get trusted health information. Whenever. Wherever... with your iPhone, iPad or Android.

Find Out More
IMPORTANT: About This Section and Other User-Generated Content on WebMD

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatment or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service, or treatment.

Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.